Sientra (SIEN) Set to Announce Quarterly Earnings on Thursday
Sientra (SIEN) Set to Announce Quarterly Earnings on Thursday
Sientra (NASDAQ:SIEN – Get Rating) will be posting its quarterly earnings results after the market closes on Thursday, August 11th. Analysts expect Sientra to post earnings of ($0.23) per share for the quarter. Sientra has set its FY 2022 guidance at EPS.Parties interested in participating in the company's conference call can do so using this link.
西恩特拉(纳斯达克：SIEN-GET评级)将在8月11日(星期四)股市收盘后公布季度收益结果。分析师预计，西门子将公布本季度每股收益为0.23美元。Sientra已经将其2022财年的指导定为EPS。有兴趣参加该公司电话会议的各方可以使用以下链接进行操作。
Sientra (NASDAQ:SIEN – Get Rating) last announced its quarterly earnings data on Thursday, May 12th. The medical instruments supplier reported ($0.29) EPS for the quarter, missing analysts' consensus estimates of ($0.26) by ($0.03). Sientra had a negative net margin of 71.61% and a negative return on equity of 498.54%. The firm had revenue of $21.40 million during the quarter, compared to analysts' expectations of $20.25 million. On average, analysts expect Sientra to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.
西恩特拉(纳斯达克：SIEN-GET评级)上一次公布季度收益数据是在5月12日星期四。这家医疗器械供应商公布了该季度每股收益(0.29美元)，低于分析师普遍预期的(0.26美元)和(0.03美元)。西门子的净利润率为负71.61%，净资产回报率为负498.54%。该公司本季度营收为2,140万美元，高于分析师预期的2,025万美元。分析师平均预计，Sientra本财年每股收益为-1美元，下一财年为-1美元。
Sientra Trading Up 7.1 %
Sientra交易上涨7.1%
Shares of NASDAQ:SIEN opened at $1.06 on Thursday. Sientra has a 52 week low of $0.70 and a 52 week high of $7.95. The company's 50 day moving average is $0.92 and its two-hundred day moving average is $1.77. The company has a current ratio of 1.59, a quick ratio of 0.95 and a debt-to-equity ratio of 2.61. The company has a market cap of $66.40 million, a PE ratio of -1.07 and a beta of 1.94.
纳斯达克：西安股价周四开盘报1.06美元。Sientra的52周低点为0.70美元，52周高点为7.95美元。该公司的50日移动均线切入位在0.92美元，200日移动均线切入位在1.77美元。该公司的流动比率为1.59，速动比率为0.95，债务权益比率为2.61。该公司市值为6,640万美元，市盈率为-1.07，贝塔系数为1.94。
Institutional Trading of Sientra
Sientra的机构交易
Analyst Ratings Changes
分析师评级发生变化
SIEN has been the topic of a number of recent analyst reports. Lake Street Capital started coverage on shares of Sientra in a research report on Thursday, April 14th. They issued a "buy" rating and a $8.00 price objective on the stock. Maxim Group reaffirmed a "buy" rating and issued a $5.00 target price on shares of Sientra in a research report on Friday, May 13th. StockNews.com downgraded shares of Sientra from a "hold" rating to a "sell" rating in a research report on Tuesday, May 10th. Finally, Canaccord Genuity Group dropped their target price on shares of Sientra from $8.00 to $5.00 in a research report on Friday, May 13th. One analyst has rated the stock with a sell rating and six have assigned a buy rating to the stock. Based on data from MarketBeat.com, Sientra has a consensus rating of "Moderate Buy" and a consensus target price of $7.29.
Sien一直是最近许多分析师报告的主题。Lake Street Capital在4月14日星期四的一份研究报告中开始报道Sientra的股票。他们对该股的评级为“买入”，目标价为8.00美元。Maxim Group在5月13日(星期五)的一份研究报告中重申了对Sientra的“买入”评级，并对其股票发布了5.00美元的目标价。在5月10日周二的一份研究报告中，StockNews.com将Sientra的股票评级从持有下调至卖出。最后，在5月13日星期五的一份研究报告中，Canaccel Genuity Group将Sientra的股票目标价从8.00美元下调至5.00美元。一名分析师对该股的评级为卖出，六名分析师对该股的评级为买入。根据MarketBeat.com的数据，Sientra的共识评级为“适度买入”，共识目标价为7.29美元。
About Sientra
关于Sientra
(Get Rating)
(获取评级)
Sientra, Inc, a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names.
Sientra，Inc.是一家医学美学公司，在美国和国际上开发和销售医学美学产品。该公司提供用于隆胸和乳房再造手术的硅胶乳房植入物；乳房组织扩张器；以及Sientra圆形、Sientra TearDrop、allX2、Dermaspan、SoftSpan和BIOCORNEUM品牌的疤痕处理产品。
See Also
另请参阅
- Get a free copy of the StockNews.com research report on Sientra (SIEN)
- There Are Different Types of Stock To Invest In
- Is it Time to Tap Molson Coors or Will Beer Sales Turn Flat?
- Is Starbucks Shooting For The Moon?
- PayPal Continues To Struggle As Competition Increases
- Two High-Yield Deep-Values You Shouldn't Ignore
- 免费获取StockNews.com关于Sientra的研究报告(SIEN)
- 有不同类型的股票可供投资
- 是时候开发Molson Coors了，还是啤酒销售会变得平淡？
- 星巴克是在向月球进军吗？
- PayPal继续挣扎，竞争加剧
- 你不应该忽视的两个高收益深度价值
Receive News & Ratings for Sientra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra and related companies with MarketBeat.com's FREE daily email newsletter.
接受西恩特拉日报的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Sientra和相关公司的最新新闻和分析师评级的每日简明摘要。
译文内容由第三方软件翻译。